Western University

Scholarship@Western
Electronic Thesis and Dissertation Repository
12-13-2021 7:00 PM

Validation of the FlexCell®FX-5000 Tension System to Evaluate
the Expression of Cementum Protein-1 in Human Periodontal
Ligament Cells While Under Cyclical Orthodontic Tensile Force
Allison Nicholls, The University of Western Ontario
Supervisor: Dr. Douglas Hamilton, The University of Western Ontario
Co-Supervisor: Dr. Ali Tassi, The University of Western Ontario
A thesis submitted in partial fulfillment of the requirements for the Master of Clinical Dentistry
degree in Orthodontics
© Allison Nicholls 2021

Follow this and additional works at: https://ir.lib.uwo.ca/etd
Part of the Orthodontics and Orthodontology Commons

Recommended Citation
Nicholls, Allison, "Validation of the FlexCell®FX-5000 Tension System to Evaluate the Expression of
Cementum Protein-1 in Human Periodontal Ligament Cells While Under Cyclical Orthodontic Tensile
Force" (2021). Electronic Thesis and Dissertation Repository. 8359.
https://ir.lib.uwo.ca/etd/8359

This Dissertation/Thesis is brought to you for free and open access by Scholarship@Western. It has been accepted
for inclusion in Electronic Thesis and Dissertation Repository by an authorized administrator of
Scholarship@Western. For more information, please contact wlswadmin@uwo.ca.

Abstract
The pressure-tension theory of orthodontic tooth movement (OTM) states that there are
differences in microenvironment between the tension and compressions side within the
periodontal ligament, leading to differential gene expression within those zones. Cementum
protein 1 (CEMP-1) is a human-specific protein localized to the root of a tooth and may play
a role in OTM. The first objective was to develop a protocol to apply tensile force to human
PDL cells similar to that within the tension zone during OTM. For this, the FlexCell®FX-5000
Tension system was used and fluorescent microscopy was used to confirm validity of the
protocol. The second objective was to evaluate expression of CEMP-1 in human PDL cells
under tensile force using RTqPCR. Expression of CEMP-1 appeared to decrease over time
regardless of amount of force application or time point. More research is required to further
investigate CEMP-1 expression in human PDL cells.
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Summary for Lay Audience
Orthodontics is the dental specialty that addresses the diagnosis, prevention and correction of
malpositioned teeth and jaws. Tooth movement is just one of the tools used to address dental
malocclusion. A specialized group of fibers, called the periodontal ligament (PDL), connects
the tooth to the surrounding bone and is essential for tooth movement. When a tooth is moved
through the bones of the jaw, one side of the PDL is compressed while the other side of the
PDL is experiencing tension. Because the forces are different on either side of the tooth’s PDL,
this can lead to differences in the microenvironments between the zones of compression and
tension.
Previous studies have shown that certain proteins – such as Periostin – are differentially
expressed in the different zones and this suggests that other proteins might be differentially
regulated as well. This study specifically wanted to look at how cementum protein 1 (CEMP1) was expressed in the zone of tension. CEMP-1 is only found in humans and as such there is
not much known about this protein. It is thought that it may help generate or regulate
components that help repair teeth during orthodontic tooth movement.
In order to evaluate CEMP-1 expression in an environment as similar as possible to that found
in humans, a protocol was developed using a specialized machine (FlexCell®FX-5000 Tension
system) that could apply tension to human PDL cells isolated from extracted teeth in a 3dimensional collagen gel. Using this protocol, it was determined that CEMP-1 expression
decreased over time with or without tension applied. Additional research is required to more
fully understand the role of CEMP-1 in orthodontic tooth movement.
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Chapter 1 – Introduction
1.1 Orthodontic tooth movement:
Orthodontics is the dental specialty that addresses the diagnosis, prevention, and correction
of malpositioned teeth and jaws1. According to the Canadian Association of Orthodontists,
the purpose of orthodontic treatment includes the “application and control of corrective
appliances to bring teeth, lips and jaws into proper alignment and achieve facial balance”2.
A stable bite can not only improve the patient’s self-esteem but also improve multiple
functional aspects of their life including improved sleep, mastication, swallowing and
breakthing1. Figure 1 depicts an example of the results possible from comprehensive
orthodontic treatment.

a)

b)

c)

Figure 1: Example of results possible from comprehensive orthodontic treatment.
This patient had comprehensive orthodontic treatment at the Western University Graduate
Orthodontics Clinic and their initial (a), progress (b) and final (c) photographs are shown. Their
treatment plan included upper and lower orthodontic appliances, dental unit extractions and
temporary anchorage devices.
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Tooth movement is just one of the tools used to address dental malocclusion. When a
prolonged force or mechanical stimuli is applied to a tooth, this initiates a series of complex
cellular signalling processes within the periodontal ligament (PDL) that lead to tissue and
bone remodeling around the tooth and eventual orthodontic tooth movement (OTM)3.
In general, OTM occurs in three phases1. The first phase involves initial tooth movement
1-2 days after orthodontic force application accompanied by alterations in blood flow
associated with tension sites (where blood vessels are stretched) and compression sites
(where blood vessels are crushed) within the PDL. The second phase occurs 20 to 30 days
after orthodontic force application, where there is a buildup of hyalinization and tissue
necrosis in the compressed areas of the PDL that causes OTM to cease. Once necrotic tissue
has been removed, the final phase begins and OTM resumes.
Three different models have been suggested to describe OTM. First, the “Pressure-Tension
Theory” of orthodontic tooth movement is the most widely accepted model for OTM and
a diagrammatic representation is seen in Figure 2. This theory states that tooth movement
is the sum of inducing a tensile force in the PDL on one side of the tooth leading to bone
deposition via osteoblasts and a compressive force on the other side of the tooth leading to
bone resorption via osteoclasts4. However, the Finite Element Model developed by
Cattaneo et al. showed that OTM could not be a result of symmetric compressive/tensile
stress distribution within the PDL5,6.
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Figure 2: Diagrammatic representation of the Pressure-Tension theory.
The Pressure-tension theory is the most commonly accepted theory for OTM. Tooth movement is the
sum of inducing a tensile force in the PDL on one side of the tooth leading to bone deposition
(osteoblasts) and a compressive force on the other side of the tooth leading to bone resorption
(osteoclasts). Given the differences in the microenvironment between the tension and compression
sides, this can lead to differential gene expression within the PDL during OTM.

Secondly, the “Alveolar Bending Hypothesis” agrees that the PDL has a role in OTM but
describes the importance of deformation within the alveolar bone as well7. By performing
tooth movements in isotope-labeled mice, it was determined that the alveolar bone tooth
socket acts like a cantilever for the tooth leading to a free end (crown of the tooth) and a
fixed end (root of the tooth). Rather than the symmetric movement as described in the first
theory, when an orthodontic force is applied, the free crown is displaced more than the
fixed root leading to a bending of the alveolar bone lining the tooth socket6,7.
Finally, the “Stretched Fibre Hypothesis” attempts to relate orthodontic tooth movement
with orthopedic bone remodelling8. This hypothesis is based on the orthopedic mechanostat
3

theory that states that a low force applied to bone leads to bone resorption while a high
force applied to bone leads to bone formation9. Tooth movement is thus due to the elastic
fibers in the PDL that are stretched when under tensile forces (leading to a high force and
bone formation) and squeezed when under compressive forces (leading to a low force and
bone resorption).
While each of these hypotheses is based on a slightly different principle, there is one feature
that is shared – the importance of the PDL. Ankylosed teeth – meaning teeth that lack a
PDL – are not moved by orthodontic forces, which enforces the role and importance of the
PDL and PDL-derived cells in OTM4,10.

1.2 The Periodontal Ligament
Located between the root of a tooth and the inner wall of the alveolar bone within the tooth
socket, the PDL is a vascular, highly fibrous, collagen-rich connective tissue that acts to
protect a tooth against stresses during mastication and occlusion11. Not only does the PDL
provide mechanical support against stress, it also contains several sensory and vascular
cells that can modulate cell activity in response to various stimuli12. For example, when
orthodontic appliances are activated at the level of the crown of the tooth, the forces are
transmitted through the PDL to the alveolar bone, triggering a cascade of various chemical
signalling molecules such as prostaglandins and cytokines, ultimately leading to activation
of cells that mediate tissue and bone remodelling1. As a result, an in depth understanding
of the components of the PDL is essential to evaluate orthodontic tooth movement.

1.2.1

PDL Development

The PDL is of mesenchymal origin, specifically the transient neural crest cells (NCCs)13.
NCCs are first seen during embryonic neural tube closure and migrate to the craniofacial
region14. Once in the cranial region, NCCs begin to proliferate and are termed neural crest
derived-mesenchymal cells or ectodermal mesenchymal cells, where they are involved in
the development of cranial facial bones, neural tissue and dental organs such as the dental
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follicle, pulp, dentin and periodontium14. Specifically, odontogenic epithelium invaginates
odontogenic mesenchymal tissue, which is the beginning of the start of the classic threestep tooth development pathway13:
(1)

Bud stage involves dental cells condensing to form a bud shape, known as the

enamel organ,
(2)

Cap stage follows as further proliferation and agglutination of cell mass,

(3)

Bell stage involves histodifferentiation and morphodifferentiation where there is

specific development of dental tissues such as enamel and dentin15.
Periodontal tissue begins to form during the cap stage and enamel matrix proteins such as
amelogenin (secreted from the enamel epithelium) trigger the beginning of the bell stage13.
During root development, collagen fibers (laid down by fibroblasts) are initially laid down
fairly loosely in a direction parallel to the root and as the tooth erupts and makes final
occlusal contact, these PDL fibers re-orient such that they become horizontally arranged
within the coronal third of the root, obliquely arranged within the middle third of the root
and arranged apically from the cementum surface to the alveolar bone in the apical third17.
The terminal point of insertion of these collage fibers (whether on the tooth cementum side
or on the alveolar bone side) occurs as Sharpey’s fibers17.

1.2.2
1.2.2.1

PDL Cells
Stem cells

The healthy PDL contains many different types of cell populations including fibroblasts,
endothelial cells, epithelial cell rests of Malassez, cementoblasts, sensory cells and boneassociated cells (each described in turn below)12. Additionally, the PDL contains
populations of undifferentiated mesenchymal stem cells (MSCs), also known as dental
follicle stem cells.
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MSCs have the ability to give rise to mature cell types that have characteristic
morphologies and specialized functions18. In the case of the PDL, these cells include
osteoblasts, cementoblasts and fibroblasts18. MSCs are of mesoderm origin and have the
ability for self-renewal19. Within the PDL, various growth factors and signalling molecules
will trigger an MSC to differentiate into a specific progenitor cell, namely pre-osteoblast,
pre-cementoblast or a pre-fibroblast, prior to becoming committed to differentiating along
their particular cellular developmental pathway to become an osteoblast, cementoblast or
fibroblast19. Given the potential for self-renewal, there is much ongoing research evaluating
the use of MSCs for regeneration of the PDL in the face of periodontal disease and reestablishment of the attachment apparatus20.

1.2.2.2

Fibroblasts

The most abundant cell found within the PDL are fibroblasts, and they constitute ~50-60%
of the total PDL cell composition21. These highly active cells are responsible for
maintenance of the PDL and continuously remodel the collagen fibers18. In rodent molars,
it has been shown that fibroblasts are in direct contact and communicate with neighboring
fibroblasts, which facilitates electrical coupling and chemical signalling12,22. Within the
PDL, fibroblasts are oriented parallel to the collagen fibers and apicocoronal to oxytalan
fibers23. This fibroblast-oxytalan fiber complex adds to the elastic properties of the PDL
and may also help keep blood vessels open under loading12.
Interestingly, fibroblasts have also been shown to have the ability to produce the enzyme
alkaline phosphatase (ALP)12,24. This membrane-bound enzyme plays a key role in
phosphate metabolism, specifically in the mineralization and calcification of hard tissues
(such as bone) and is a biomarker of osteoblast activity12,25. Therefore, it may be speculated
that fibroblasts within the PDL may also have an “osteoblastic” function, on top of their
role in collagen maintenance26.

6

1.2.2.3

Endothelial cells

The PDL contains a well-defined vascular system originating from alveolar bone and
gingiva and consist of two layers27:
(1)

The inner layer containing capillaries that supply the PDL cells with oxygen and

nutrients;
(2)

The outer layer containing larger vessels that play a role in absorbing forces27,28.

PDL endothelial cells can promote the proliferation of periodontal cells and thus function
in the regeneration of the PDL27,29.

1.2.2.4

Epithelial cell rests of Malassez

During the development of the periodontium, there is a collection of epithelial cells –
Hertwig epithelial root sheath (HERS) or Epithelial Root Sheath – located on the cervical
loop of the enamel organ13. By initiating the differentiation of odontoblasts from the dental
papilla, the HERS cells are responsible for dentin formation within the root of a developing
tooth13. Eventually, the HERS will disintegrate as the PDL forms, but some pieces do not
completely resolve and remain within the PDL as epithelial cell rests of Malassez30.
In addition to helping maintain PDL width, epithelial cell rests of Malassez may also play
a role in cementum regeneration and repair, and they have been implicated in development
of cysts such as the gingival or periodontal cyst30,31.

1.2.2.5

Sensory Cells

The main sensory cells within the PDL originate from the trigeminal ganglia and these
neurons are concentrated mainly in the cervical and middle root areas32. The PDL
continuously receives a variety of sensory and mechanical input throughout the day such
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as occlusal forces, masticatory forces and nociceptive input which is then sent from the
tooth to the central nervous system32.
Mechanoreceptors at the neuronal endings in the PDL convert this mechanical stimulus
into a biological response, and input from the periodontal mechanoreceptors can influence
a variety of reflex systems within the orofacial region such as unconscious sensory
feedback during mastication and proprioceptive information regarding bite force32. These
mechanoreceptors become very important in the face of orthodontic forces as orthodontic
tooth movement alters their signalling state and leads to an inflammatory response with the
release of inflammatory neuropeptides such as substance P and calcitonin Gene-related
peptides32–34.
These signalling molecules then interact with PDL endothelial cells which in turn leads to
the activation, migration and adherence of leukocytes32. Cytokines, growth factors and
colony-stimulating factors that are then secreted by the leukocytes trigger the cellsignalling cascade required to remodel bone and other dental tissue32,35.

1.2.2.6

Cementoblasts

Cementoblasts are the ectomesenchymal cells responsible for forming the cellular
cementum around the apical two thirds of the root of a tooth36. Progenitor cementoblast
cells can be found within the PDL and are triggered to become cementoblasts in the face
of periodontal tissue reconstruction and repair37.
Note that cementoclasts (cells responsible for the breakdown of cementum) have been
shown to mediate the apical external root resorption commonly seen in orthodontically
moved teeth38. Consequently, during cementum repair, local cytokines and growth factors
such as insulin-like growth factor-1, fibroblast growth factor, epidermal growth factor,
bone morphogenic proteins (BMP) and transforming growth factor-beta (TGF-b) trigger
cementoblast precursors in the PDL to become mature cementoblasts which promote
cementogenesis39,40.
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1.2.2.7

Bone cells

While there are multiple hypotheses describing orthodontic tooth movement, the most
widely accepted hypothesis is the “Pressure-Tension Theory”1. On the side of the tooth
experiencing tension, cell signalling pathways within the PDL are induced that lead to
activation of osteoblasts (cells that build up bone) while on the side of the tooth
experiencing compression, different cell signalling pathways are induced that lead to
activation of osteoclasts (cells that break down bone)1. Each of these bone-related cells are
discussed in detail below.

1.2.2.7.1

Osteoblasts

Osteoblasts are specialized mononucleated cells of mesenchymal origin that are
responsible for bone apposition41. Osteoblasts are similar in function to fibroblasts in that
they both are capable of synthesizing type I collagen; however, osteoblasts distinguish
themselves from fibroblasts in that they express a core-binding factor subunit alpha-1
(Cbfa1) and Osteocalcin41,42. Cbfa1 – also known as Runt-related Transcription Factor 2
(RUNX2) is a transcription factor which acts as a key regulator of osteoblast differentiation
and function42,43. A study by Komori et al. showed that there is complete lack of bone
formation in Cbfa1-deficient mice which demonstrates the importance of Cbfa1for
osteoblast driven ossification42,44. Specifically, one of the roles of Cbfa1 is to regulate the
expression of Osteocalcin (OCN), which is a gene only expressed in terminally
differentiated osteoblasts42.
In addition to Cbfa1 and OCN, osteoblasts rely on various other factors and proteins for
activation and maturation. For example, BMPs have been shown to commit mesenchymal
progenitor cells to become osteoblasts as well as stimulating the maturation of committed
osteoblasts45,46. Furthermore, PTH controls the expression of BMPs by activating the
extracellular signal-related protein kinase (Erk) 1/2 and nuclear factor (NF)-κB signaling
pathway47,48.
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TGF-b is a superfamily of cytokines that regulates bone and cartilage proliferation,
maturation and homeostasis. It is deposited in bone by osteoblasts during bone formation
and is released from bone during osteoclastic activity49,50. By inhibiting TGF-β in
transgenic mice, Filvaroff et al., showed that osteocyte (mature osteoblasts) density was
reduced and there was an imbalance between bone formation and resorption during
remodelling51. Furthermore, cultured osteoblast-like cells have a significant reduction in
mobility after treatment with TGF-b1, which is a characteristic of mature bone cells52.
Other critical factors for osteoblast development include the Wnt signaling pathways,
insulin-like growth factors (IGFs), osterix and fibroblast growth factor53.
As mentioned previously, mature osteoblasts are responsible for bone apposition and do so
by expressing and secreting type I collagen, ALP and OCN29. Recall that ALP is a
glycoprotein and enzyme found within the gingival crevicular fluid (GCF) of periodontal
tissue that releases phosphate ions from organic phosphate leading to the precipitation of
calcium phosphate salt54. During OTM, there is an increase in GCF ALP which peaks at
about 1 to 3 weeks of force application and as such, measurement of ALP has been
considered as a marker for bone turnover in OTM55,56. Interestingly, Parinetti et al. (2002)
demonstrated that ALP activity was temporally and spatially regulated in tension and
compression zones during OTM57.
OCN – or bone gamma-carboxyglutamic acid-containing protein (BGCAP) – is a small,
non-collagenous, protein exclusively found in osteoblasts that is necessary for the
formation and mineralization of osteoid42,43,58. Studies using an osteocalcin knock-out in
mice initially revealed a potential role for osteocalcin as an inhibitor of bone maturation as
these null mice had an increased mineral to matrix ratio59. However, more recent studies
have shown that OCN binds to hydroxyapatite and forms a complex with collagen through
osteopontin (a matrix protein)60. While the exact mechanism of action of osteopontin has
not yet been elucidated, it is known that osteocalcin can directly bind calcium and
concentrates in bone and as such has been used as a marker for bone formation61.
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1.2.2.7.2

Osteocytes

The type I collagen produced by osteoblasts eventually forms an organized organic matrix
with proteoglycans and glycoproteins now termed osteoid62. Bone formation and
maturation continues with deposition of calcium phosphate, which mineralizes the
osteoid63. During this process, osteoblasts become terminally differentiated into osteocytes,
which are then incorporated into the mineralized osteoid64.
Osteocytes reside within lacunae and have long cytoplasmic extensions that transverse
canaliculi for which exchange of nutrients and waste can occur through gap junctions
(transmembrane channels)62,65. Of note, these gap junctions may be involved in bone
response to mechanical strain – such as OTM – as mechanical forces have been shown to
cause fluid flow through these channels66.

1.2.2.7.3

Osteoclasts

Contrary to osteoblasts, which are of mesenchymal origin, osteoclasts are multinucleated
cells from the monocyte/macrophage lineage67. It has been shown that osteoclast
differentiation is supported by osteoblasts, reinforcing that there is balance between bone
resorption and bone apposition68,69.
The signalling pathways that trigger osteoclasts to commence differentiating from
precursor cells are complex and involve various factors such as 1a,25-dihydroxyvitamin
D3 and PTH, which leads to the production of receptor activator of NF-kB ligand
(RANKL)70,71. RANKL binds to receptor activator of NF-kB (RANK) on osteoclast
precursor cells which triggers a cell-signalling cascade71,72.
This cascade begins with the recruitment of TNF receptor-associated factor (TRAF) family
proteins that then activate NF-kB and mitogen-activated protein kinase (MAPKs) which
subsequently activates transcription factors required for osteoclast differentiation (c-fos,
PU.1, NFATc1)72. The RANK-RANKL system is essential for osteoclast regulation as
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disruption of either RANK or RANLK results in osteopetrosis (abnormally dense bone)
due to impaired osteoclast differentiation73,74.
Once mature, various interleukins (IL-1b, IL-6) and Prostaglandin E2 (PGE2) signal
osteoclasts to start resorbing bone75. Activated osteoclasts are found within Howship’s
lacunae, which are pits in the surface of the bone they are resorbing67. Here, the osteoclasts
create an acidic microenvironment and produce vacuoles filled with various enzymes
required to break down the collagen within bone (demineralization) such as tartrate
resistant acid phosphatase (TRAP), matrix metalloproteinases (MMPs) and Cathepskin K
(which breaks down collagen within bone)67,76. At the site of bone resorption, osteoclasts
form a specialized ruffled border to increase surface area for maximum secretion of these
bone-resorbing proteases67,76.
Another connection between osteoclast and osteoblast function is osteoprotegerin (OPG).
OPG – also known as osteoclastogenesis inhibitory factor (OCIF) or tumor necrosis factor
receptor super family member 11B (TNFRSF11B) – is largely expressed by osteoblasts
and acts as a decoy for RANKL77,78. OPG binds to RANKL preventing RANKL from
binding to its receptor, RANK, eventually leading to reduction of osteoclast function and
subsequent apoptosis79. Of note, there has been some research in using recombinant OPG
or other inhibitors of RANKL as a means to block osteoclast function in the face of OTM
to provide additional orthodontic anchorage80.

1.3 PDL Extracellular Matrix (ECM)
The main structural component of the PDL is collagen that is organized into cross-banded
fibrils12. Specialized Type I and III collagen fibers (Sharpey’s fibers) firmly attach the
periosteum of the alveolar bone and the cementum on the root of the tooth12,81. Note that
Type V, VI and XII collagen can also be found associated with, buried within or found in
the spaces between main Sharpey’s fibers fibril bundles81–84. In addition to providing
structural support for the PDL, collagen can mediate cell-signalling events and provide
substrates for cell adhesion 85,86.
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Another fiber type present in the PDL are oxytalan fibers. As mentioned previously, these
fibers help protect blood vessels by keeping them patent during loading and typically run
from the cementum to outside of the blood vessels12.
In addition to various fibers, the PDL ECM is also comprised of various proteoglycans
and glycoproteins.
Proteoglycans (PG) are comprised of a core protein with one or more highly anionic
glycosaminoglycans (GAG). They are present in virtually all connective tissue
extracellular matrices and as such, it is no surprise that PGs are found within the PDL87.
Given the highly anionic GAGs, PGs help provide hydration to the ECM by attracting
cations (such as sodium, potassium, calcium) and water, which in turn helps cushion and
protects against compressive forces, provides lubrication and nutrient delivery88.
Glycoproteins, such as undulin, tenascin and fibronectin, are non-collagenous proteins that
contain a covalently bonded glycan (oligosaccharide chain) and can also be found within
the PDL ECM89. These molecules play a role in ECM organization and signal
transduction89. Undulin is localized between densely packed mature collagen fibrils and
likely plays a role in the supramolecular and functional organization of collagen fibrils into
flexible bundles thus allowing for limited gliding between individual collagen fibrils90,91.
Contrarily, tenascin is localized between loosely packed collagen fibres and is expressed
during development, disease or injury91. Fibronectin is more broadly distributed than both
undulin and tenascin, and it shows a close association with type I and III collagen and can
bind fibroblasts92. Additionally, it has been shown that tenascin can interact with
fibronectin thus reducing its ability to bind fibroblasts93.
More recently, a novel glycoprotein classified as a matricellular protein family member –
Periostin (PSTN) – was found to be expressed by fibroblasts in the periodontal ligament
and osteoblasts in the alveolar bone and is responsible for the maturation, stability and cell
signalling within the PDL94–96. Additionally, periostin has been implicated in a variety of
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disease processes such as tumorigenesis and metastasis, cardiac repair, diabetes and
obesity, bronchial asthma as well as wound healing97–101.
Relating to the field of orthodontics, this 90-kDa extracellular matrix protein has been
specifically implicated in promoting tooth movement during orthodontic treatment94.
Using cultured human periodontal ligament (hPDL) cells, Xu et al. determined that
periostin expression increases when under orthodontic forces94. This same research group
also determined that periostin expression levels increase in murine periodontal ligaments
during OTM94.
Additional research has shown that PSTN is upregulated specifically in the compression
zone of the PDL compared to that within the tension zones of the PDL and that mice lacking
the periostin gene have reduced rates of OTM95,102. Note that expression of periostin did
increase in both the compression and tension zones, however PSTN increased to a greater
degree in the zone of compression relative to the zone of tension95,102. If periostin is
differentially expressed in compression versus tension zones, it is important to discuss
other proteins/products that are differentially and spatially regulated during OTM.
Table 1 summarizes the components of the PDL ECM.
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Table 1: Summary of PDL ECM components.
ECM Component
Fibroblasts
Collagen
Type I & III
Collagen Type V
Collagen
Type VI & XII
Oxytalan Fibers
Proteoglycans

Glycoproteins:

Function
Most abundant cell in the PDL. Continuously remodels
collagen21.
Sharpey’s fibers. Core fibril of the PDL ECM. Connect
periosteum to bone12.
Minor collagen associated with the Sharpey’s fibers. Is found
buried within the core or found in between the spaces of the core
fibrils12.
Minor collagen. Help contribute to the construction of the 3dimensional fibril arrangement12.
Protection of blood vessel integrity while under loading23.
Helps provide hydration to the ECM by attracting cations88.
Localized between densely packed mature
Undulin
collagen fibrils. Likely plays a role in the
functional organization of collagen fibrils89.
Localized between loosely packed collagen fibrils.
Tenascin
Likely involved in wound healing89.
Broadly distributed. Closely associated with type I
Fibronectin
and III collagen92.
Implicated in a variety of disease processes such
as tumorigenesis and metastasis, cardiac repair,
Periostin
diabetes and obesity, bronchial asthma as well as
wound healing94.

1.4 Gene expression during OTM:
As mentioned previously, “Pressure-Tension Theory” of OTM states that tooth movement
is the sum of inducing a tensile force in the PDL on one side of the tooth leading to bone
deposition, and a compressive force on the other side of the tooth leading to bone
resorption4. Within minutes of orthodontic force application, blood vessels within the PDL
are dilated on the tension side and partially compressed on the pressure side1.
This changes the blood flow to those areas, leading to changes in oxygen tension and
release of prostaglandins and cytokines and if force is sustained, secondary cellular
messengers such as cyclic adenosine monophosphate (cAMP) are upregulated by 4 hours1.
cAMP then goes onto regulating differentiation of osteoclasts and osteoblasts as well as
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leading to multiple downstream effects such as production of mediators related to
inflammation4,103. As can be imagined, given the differences in the microenvironment
between the tension and compression side, this can lead to differential gene expression
within the PDL.
By applying compressive force to human PDL-derived fibroblasts for 6 days, Rankovic et
al., was able to evaluate the temporal expression of various genes related to
mechanosensing (cFOS, HB-GAM), inflammation (COX2, IL-6, TNF-α), bone
remodelling (RUNX2, P2RX7)103. For this experiment, human PDL cells were isolated
from the roots of extracted teeth, cultured in vitro and compressed using a glass cylinder
for varying amounts of time103,104. Next, total mRNA was isolated and quantitative RTPCR was performed in order to evaluate relative amounts of expressed of the genes listed
above103.
In summary the above article showed that when under compressive forces cFOS was upregulated; HB-GAM expression was only up-regulated on day 5 of compression; IL-6 and
COX2 reached maximum expression after 3 days of compression; TNF-α was overall upregulated except on day 2 of compression; P2RX7 was down-regulated on days 2, 4, 5, 6
of compression; and RUNX2 was down-regulated on days 2 and 5 of compression103.
Complementing the data concerning gene expression in PDL cells under compressive
force, another research group evaluated gene expression with PDL cells under tensile
force105. For this, human subjects were treated with a palatal expander after which
premolars were extracted immediately after expander removal. By performing RT-qPCR
on PDL cells isolated from the palatal side of the extracted tooth, this gave researchers a
sampling of the mRNA in cells exposed to tensile force. It was determined that there is
increased expression of IL-10, tissue inhibitor metalloproteinases (TIMP-1), COL-I,
osteoprotegerin, and osteocalcin which all exhibit anti-inflammatory properties105.
Interestingly, this group also investigated gene expression while under compressive force
as well by evaluating PDL cells on the labial side of the extracted tooth and revealed higher
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expression of pro-inflammatory cytokines such as NFκB, RANKL and MMPs which
corroborates the data by Rankovic et al., that also showed up-regulation of proinflammatory cytokines.
A limitation to both these studies is that a set of pre-selected genes to evaluate during
compressive or tensile forces were used; however, it can be imagined that there are many
other genes also expressed during orthodontic tooth movement that were not evaluated.
More specifically, much of the research presented involves looking at gene expression
specifically within the PDL during OTM, but perhaps there are other factors at play, such
as tooth root-specific factors such as those involving the cementum.
Table 2 summarizes gene expression during OTM.
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Table 2: Summary of components involved in gene expression during OTM.
Gene
cFOS
COX2
HB-GAM
IL-6
IL-10

Gene Name
Fos proto-oncogene,
AP-1 transcription
factor subunit
Cyclooxygenase-2
Heparin-binding
growth-associated
molecule,
Pleiotrophin
Interleukin-6
Interleukin-10

MMPs

Matrix
metalloproteinases

NFκB

Nuclear factor kappalight-chain-enhancer
of activated B cells

OCN

Osteocalcin

OPG

Osteoprotegerin

P2RX7

P2X purinoceptor 7

RANK

Receptor activator of
nuclear factor- κB

RANK-L
RUNX2

Receptor activator of
nuclear factorκΒ ligand
Runt-related
transcription factor 2

TIMP-1

Tissue inhibitor of
metalloproteinase-1

TNF-α

Tumor necrosis
factor-α

Role in OTM
Involved in PDL mechanosensing103.
Enzyme involved in the inflammatory
cascade103.
Involved in PDL mechanosensing103.
Pro-inflammatory cytokine103.
Anti-inflammatory cytokine105.
Protease that degrades extracellular matrix
components such as collagen. Involved in
destructive periodontal diseases106.
Pro-inflammatory cytokine67.
Only expressed in terminally differentiated
osteoblast. Binds calcium directly. Biomarker of
bone formation58.
Expressed by osteoblasts. Acts as a decoy ligand
for RANK, blocking RANK-L therefore
reducing osteoclast differentiation and
activation105.
ATP-dependent ion channel. Plays a role in bone
remodeling and inflammation. Mediates the
release of pro-inflammatory mediators that are
involved in the regulation of bone
homeostasis107.
Receptor for the RANK-L. Part of the pathway
that regulates osteoclast differentiation and
activation105.
Ligand for RANK. Part of the pathway that
regulates osteoclast differentiation and
activation105.
Key transcription factor associated with
osteoblast differentiation79.
Non-specifically inhibits almost every member
of the MMP family. Plays a physiologic role in
the turnover of periodontal tissue105.
Pro-Inflammatory cytokine103.
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1.5 Cementum repair during OTM:
As described previously, OTM leads to an area of reduced oxygen tension within the
compression side of the PDL, which then leads to a localized area of ischemia within the
PDL itself, and the adjacent alveolar bone108. This leads to an area of necrosis/hyalinization
which must eventually be removed by osteoclasts/cementoclasts, potentially leading to
collateral damage of the superficial layer of acellular cementum in that same area109.
Cementoclasts resorb cementum and have a similar structure as osteoclasts in that they are
multi-nucleated, have ruffled borders and produce TRAP110. However, unlike osteoclasts,
the molecular pathways that drive their differentiation and activity are not as well
understood40.
Acellular cementum resorbed by cementoclasts can be replaced with new cellular
cementum from cementoblasts and depending if the balance in cementoclast/cementoblast
activity is unfavourably skewed in favour of cementoclasts, external apical root resorption
(EARR) can result40. While approximately 80% of patients experience EARR during OTM
(particularly on maxillary incisors), the affected cementum is typically repaired to an
acceptable degree with cementoblast-derived cellular cementum40,111. However, in
approximately 5% of EARR cases, there is more than 5mm of apical root resorption and
EARR is considered to be severe111,112. In these instances, the underlying dentin is affected
and there is permanent loss of root length, potentially increasing the risk of tooth loss1.
Determining which patients are at an increased risk for severe EARR is complicated given
the number of intrinsic genetic factors, polymorphisms in gene expression, local
anatomical factors and hormonal differences that all play a role in risk assessment40. For
example, Sharab et al., 2014 determined that a specific genotype of P2RX7 (SNP
rs208294) was significantly associated with EARR demonstrating a genetic susceptibility
severe resorption112. From this and other research, it is clear that reducing the risk of EARR
is multifactorial and involves maintaining a proper balance of cementum resorption and
deposition during OTM.
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Recently, molecular cloning, bacterial expression and immunolocalization identified a
novel human cementum-derived protein (CP-23) that is expressed by cementoblasts and
subpopulations of PDL cells113. This glycosylated, phosphorylated and thermostable
protein – also known as cementum protein 1 (CEMP-1) – is localized to the root of a tooth
as well as paravascularly to the blood vessels within the PDL and is proposed to be a
candidate for a PDL-cementum specific marker113,114.
Research has shown that CEMP-1 promotes attachment of PDL fibroblasts, is implicated
in regulating HAP crystal deposition and can increase the expression proteins implicated
in cementogenesis such as ALP, osteopontin, BSP and OCN115–118. Additionally, another
research group used immunocytochemical analysis to evaluate the effects of CEMP-1 overexpression in human periodontal cells retrieved from extracted teeth with clinically healthy
periodontium and determined that CEMP-1 enhances cementoblast differentiation and
attenuated osteoblastic phenotypes119.
This is a key finding in the field of periodontal disease and OTM-related EARR as perhaps
CEMP-1 may activate cementoblast progenitors to promote cementogenesis and could thus
skew the balance of cementoblasts/cementoclasts in favour of cementogenesis.
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Chapter 2 – Rationale, Hypothesis and Objectives of the
Research
2.1 Rationale
CEMP-1 is a protein involved in cementogenesis that is expressed by cementoblasts and
subpopulations of PDL cells; however, unlike other periodontal proteins/elements (such as
periostin) that are found both in humans and in an animal experimental model, CEMP-1 is
only found in humans120,121.
Because CEMP-1 is only found in humans, this makes studying its role in OTM more
challenging as PDL cells must be retrieved from a human source rather than using a wellestablished murine cell line (for example). Given the challenges of studying a protein only
found in human cells combined with the relatively recent discovery of CEMP-1, much less
is currently known about this protein, making it a prime target for further research.

2.2 Hypothesis
Given that OTM involves replacement of resorbed acellular cementum with new cellular
cementum, perhaps CEMP-1 is also involved in the complex process of OTM. Specifically,
it is proposed that CEMP-1 might be differentially regulated under tensile and compressive
forces – such as those seen in OTM95,102.

2.3 Objectives
2.3.1

To establish a technique to apply tension to human PDL
cells in a 3-Dimensional collagen gel.

Knowing that genes are differentially expressed in zones of compression and zones of
tension, a protocol was developed to place human PDL cells isolated from extracted teeth
into a collagen gel and cyclically stretched using the FlexCell®FX-5000 Tension system
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to apply a tensile force similar to what would be experienced in OTM. Note that previous
experiments evaluating gene expression in PDL cells often use a 2-dimensional flat plate
for experimentation; however, the PDL in vivo is 3-dimensional94. Accordingly, the
development of this protocol involved plating hPDL cells in a 3-dimensional collagen gel
to better approximate the condition seen in vivo.
Also, this portion of the experiment can be considered one-sided with regards to the
overarching goal of differential gene expression during OTM as this experiment only
focuses on the tension component. Another experimental protocol will need to be
developed in the future focusing specifically on the compression component.
To confirm validity of the tension-applying protocol and ensure the hPDLs were still
viable, fluorescent microscopy was completed. Given that Oortgiesen, et al., demonstrated
that PDL fibroblasts align perpendicular to the force of application, it is hypothesized that
when hPDL cells have been exposed to tension, they will also appear aligned perpendicular
to the direction of force application whereas cells that have not been exposed to tension
will be more randomly dispersed122.

2.3.2

To evaluate CEMP-1 gene expression during cyclical tensile
force.

Using the FlexCell®FX-5000 Tension system and the protocol established in Objective 1,
tension forces were applied to the hPDL cells for various amounts of time at various force
levels. Once the mRNA was isolated, reverse transcriptase-quantitative polymerase chain
reaction (RT-qPCR) was used to look specifically for CEMP-1 expression.
It is hypothesized that CEMP-1 will be up-regulated when under tensile force, thus
providing a cementum-protective effect or perhaps promoting cementogenesis (mirroring
how osteoblasts promote bone apposition on the tension side). If CEMP-1 does have a
cementum-protective effect, perhaps this could be a novel target to evaluate which patients
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might be at higher risk for EARR during OTM by skewing the balance in favour of
cementogenesis over cementum resorption.
Note that other genes with known and expected responses to tension were also evaluated
at the same time as CEMP-1 as further confirmation of the validity of the FlexCell®FX5000 Tension system protocol. As previously mentioned, hPDL-derived Periostin activity
is known to increase in the zone of tension (recall that an increase is seen both in the zone
of tension and zone of compression during OTM but it increases more in the zone of
compression relative to the zone of tension)95,102.
It is also known that similar to Periostin, hPDL-derived bone sialoprotein (BSP) (a
component of mineralized tissue such as bone, dentin, cementum and calcified cartilage)
also increases with the application of tensile force123.
Contrary to Periostin, hPDL-derived alkaline phosphatase (ALP) (a protein enzyme
involved in mineralization and calcification of hard tissue and is a biomarker of osteoblast
activity) is known to be modulated by orthodontic forces and has been shown to decrease
with the application of tension54.
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Chapter 3 – Materials and Methods
3.1

Materials and Solutions

Dulbecco’s Modified Eagle Medium (DMEM), CO2-Independent Medium, heatinactivated fetal bovine serum (FBS), antibiotic solution (100U/ml penicillin and 100
μg/ml streptomycin), trypsin solution and phosphate buffered saline (PBS) were obtained
from GIBCO (Life Technologies Inc., Burlington, ON, Canada). TRIzol reagent, UltraPure
distilled water (DNase/RNase-free), Rhodamine phalloidin (lot 2053476) and Hoechst
33342, Trihydrochloride, Trihydrate, 10 mg/mL Solution (lot 1830258) were obtained
from Invitrogen (Life Technologies Inc., Burlington, ON, Canada). Collagen (Nutragen®
Type 1 Bovine Collagen Solution 6mg/mL) was obtained from Advanced Biomatrix
(Cedarlane,

Burlington,

ON,

Canada).

HEPES

(4-(2-hydroxyethyl)-1-

piperazineethanesulfonic acid), paraformaldehyde, bovine serum albumin (BSA) and
Triton™ X-100 were obtained from Sigma-Aldrich (Sigma-Aldrich Canada, Oakville, ON,
Canada). Linear TissueTrain® sterile cell culture plates and the FlexCell®FX-5000
Tension system was obtained from FlexCell® International Corporation (Burlington, NC,
United States). RNeasy Mini Kit was obtained from QIAGEN (Toronto, ON, Canada).
iTaq Universal Probes One-step Kit and 2xiTaq™ Universal probes one-step reaction mix
was obtained from Bio-Rad Laboratories (Mississauga, ON, Canada). Probes for CEMP-1
(Hs04185363_s1, lot P210623-Q00), BSP (Hs00913377_m1, lot 188351), ALP
(Hs0129144_m1, lot 1967391), PSTN (Hs01566750_m1, lot 1472190) and 18S rRNA
((DQ) Oligo mix, lot 1907042) were obtained from Applied Biosystems (Life
Technologies Inc., Burlington, ON, Canada).

3.2 Cell Culture
Healthy periodontal ligament was obtained after routine extraction of third molars and
premolars in the Oral Surgery Clinic at The University of Western Ontario. Each patient
had no signs of inflammation in the periodontal tissues (no bleeding, probing depth < 3mm,
no visible plaque). Explant cultures were initiated to derive the fibroblastic cells as
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previously described by Silverio-Ruiz et al., 2007124. Procedures involving human tissue
were approved by the Western University Review Board for Health Sciences Research
Involving Human Subjects and are in accordance with the 1964 Declaration of Helsinki.
All tissues were collected with consent from patients and with approval from the Western
University Health Science Research Ethics Board.
For fluorescent microscopy, hPDL cells isolated from a 43-year-old female (43F, originally
preserved at P1 on 27.08.18) were used.
For mRNA isolation and RTqPCR, hPDL cells isolated from a 28-year-old male (28M,
originally preserved at P3 on 14.08.18), a 38-year-old-female (38F, originally preserved at
P1 on 24.08.18) and a 31-year-old male (31M, originally preserved at P3 on 01.07.20) were
used.
The hPDL cells were maintained every 72 hours using DMEM supplemented with 10%
FBS and 1% antibiotic solution at 37°C in a humidified atmosphere of 5% CO2. The cells
were washed using PBS, dissociated from the surface of the culture flask using 0.25%
trypsin and split/resuspended for future experiments. Primary cells were passaged at least
four times prior to using for any experimentation.

3.3 TissueTrain®
Once hPDL cells reached at least their fourth passage, hPDL cells were seeded into
TissueTrain® 3D culture system plates (Figure 3a) at a concentration of 75,000
cells/TissueTrain® in a 3mg/mL purified bovine type 1 collagen (Nutragen®, 6mg/mL)
gel using 1.58M HEPES (pH 8.0), both stored at 4°C or on ice prior to using. These
reagents were added to each 150μL TissueTrain® as follows: 72.12μL of type 1 collagen,
5.7μL of HEPES and 72.12μL of hPDL cells in DMEM.
Note that cells were seeded into the TissueTrain® plates using a vacuum suction (Figure
3b) and were left to set for 1 hour prior to adding 3mL DMEM culture medium to each
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well. At this point, the vacuum suction was removed and the collagen gels were left to set
for 48 hours at 37°C in a humidified atmosphere of 5% CO2 (Figure 3c).
Once the gels were completely set, the TissueTrain® plates were transferred to the
FlexCell®FX‑5000 Tension system after being washed using PBS and the media was
replaced with CO2-independent culture media.

a)

b)

c)

d)

Figure 3: Photographs of the TissueTrain® culture system.
The FlexCell® TissueTrain® plates (a) have a flexible bottom with collagen tabs (b) that when
combined with the vacuum suction apparatus (c) creates a mould for the 3D collagen gels. Once the
collagen gels have set, media is added (d) and the gels are ready for tension application.
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3.4 FlexCell®FX-5000 Tension system
Cells prepared in the TissueTrain® plates described above were placed under cyclical
tensile stress loading using the FlexCell®FX-5000 Tension system. Tension protocol
included a 5 second stretch followed by a 5 second release, repeated 6x/minute at 37°C in
a humidified atmosphere without CO2.
When using the TissueTrain® plates for fluorescent microscopy, the cells were loaded at
a 10% extent for 72 hours. Cells cultured without tensile stress loading under the same
conditions served as the control. Both the experimental and control conditions were
completed in triplicate.
When using the TissueTrain® plates for mRNA isolation and RTqPCR, the cells were
loaded at 10% or 20% for either 0, 24 or 72 hours. Cells cultured without tensile stress
loading under the same conditions served as the control. Both the experimental and control
conditions were completed in triplicate with three different sets of hPDL cells.

3.5 Fluorescent Microscopy
Fluorescent microscopy was used to visualize how hPDL cells were responding to the
tension force applied by the FlexCell®FX‑5000 Tension system and to ensure that the cells
were still viable. For this experiment, 43F hPDL cells (P6) were plated in the TissueTrain®
plates and loaded as described above.
After the plates were loaded for 72 hours, the cells (still within the collagen gels) were
rinsed with PBS and fixed using a 4% paraformaldehyde (PFA) solution for 8 minutes.
Following an additional three rinses with PBS, the cells were stained for fluorescent
microscopy.
hPDL cell membranes were permeabilized with 0.1% Triton X-100 and blocked with 1.0%
bovine serum albumin (BSA) for 30 minutes. 1:100 Rhodamine phalloidin and 1:1000
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Hoechst was added and incubated in the absence of light for an additional 45 minutes. A
final rinse with PBS was completed prior to imaging.
Images of hPDL cells within the collagen gels were taken on a Carl Zeiss Imager M2m
microscope (Carl Zeiss; Jena) using ZenPro 2012 software at 10x magnification. The
DsRed channel (558nm) was used to evaluate the Rhodamine phalloidin stain and then
DAPI channel (405nm) was used to evaluate the Hoechst stain. An image representative of
the whole collagen gel was taken as Z-stacks and presented as either the DsRed channel
alone, as the DAPI channel alone or as a combination of both.

3.6 mRNA Isolation
mRNA isolation and RTqPCR was used to evaluate gene expression in hPDL cells after
cyclical tensile loading from the FlexCell®FX‑5000 Tension system. For this experiment,
hPDL cells from three different individuals – 28M (P5), 38F (P4) and 31M (P5) – were
plated in the TissueTrain® plates in triplicate and loaded as described above. Refer to
Figure 4 for an overview of this portion of the protocol.
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Figure 4: Overview of samples used for mRNA isolation and RTqPCR.
hPDLs from three samples (28M [P5], 38F [P4] and 31M [P5]) were propagated and plated into
TissueTrain® gels. Each TissueTrain® condition (0%, 10% and 20% force at 0hrs, 24hrs and 72hrs)
was repeated in triplicate for each hPDL sample for a total of 81 TissueTrain® gels. For the RTqPCR
experiments, each sample was subsequently run in triplicate for each gene evaluated (ALP, BSP,
CEMP-1, PSTN, 18S RNA). Data was normalized to 18S mRNA and presented as a fold change in
expression relative to 0hrs.

To isolate total mRNA from the hPDL cells in the TissueTrain® gels, the TRIZOL®
reagent (Invitrogen, Paisley, UK) and RNeasy kit was used to extract total RNA, using the
manufacturer’s instructions. The amount of RNA was determined using a NanoDrop 2000c
Spectrophotometer (Thermo Fisher Scientific) by measuring absorbance at 260 nm. RNA
quality was deemed adequate if the absorbance ratio of A260/A280 was within 1.9-2.1 and
if the absorbance ratio of A260/A230 was greater than 2. RNA samples were normalized
to 8ng/µL using RNase free water and then stored at -80°C until ready for amplification
using RTqPCR.
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Note that there was a building-wide power failure during the total RNA isolation from the
hPDL cells isolated from the 31-year-old male, resulting in the mRNA being left on the
RNeasy column for 1 hour prior to elution rather than the recommended 2 minutes. As
such, the overall yield of total mRNA from this sample was less than the other two samples
and further implications of this is discussed below.

3.7 Reverse Transcriptase-Quantitative Polymerase Chain
Reaction
RT-qPCR was completed using the ViiA 7 Real-Time PCR System (ThermoFisher) and
Quant Studio v1.2.4 software (Life Technologies) located at the Robarts Research Institute
at the University of Western Ontario. Each reaction was performed in triplicate using a
15µL final volume containing 32ng of each RNA sample, 2xMasterMix, iScript Reverse
transcriptase and one of the pre-mixed 10µM primers and probes (ether CEMP-1, PSTN,
ALP, BSP) on a 384-well plate. An additional set of reactions was completed using 18S
rRNA primers and probes as a normalization target. Reverse transcription was performed
at 50°C for 10 min followed by 40 cycles of amplification at an annealing temperature of
60 °C. Fold change in gene expression was calculated by normalizing to the time zero
control.

3.8 Statistical Analysis
Data is presented individually for each set of hPDL cells. While each PCR reaction and
TissueTrain® gels were performed in triplicate, more data needs to be collected to increase
the sample size (ie. More sets of hPDL cells) so that a proper statistical analysis can be
completed.
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Chapter 4 – Results
4.1 Validation of the FlexCell®FX-5000 Tension system
Protocol using fluorescent microscopy
Fluorescent microscopy was used to visualize hPDL cells isolated from a 43-year-old
female (P6) in a 3mg/mL collagen gel TissueTrain® incubated in a 37°C in a humidified
atmosphere without CO2 for 72 hours, either with a cyclical tension force application (5
second stretch at 10% tension force followed by a 5 second release, repeated 6x/minute
using the FlexCell®FX-5000 Tension system) or without tension force (0% tension force).
Hoechst was used to evaluate the viability of the hPDL cells as it stains DNA and allows
assessment of nuclear morphology125. Figure 5 demonstrates that the hPDL cells from both
the experimental condition (Figure 5a, 10% cyclical tension force application) and the
control condition (Figure 5b, 0% tension force application) are viable as the Hoechst
staining reveals nuclei that are intact, ovoid and uniform.
Rhodamine phalloidin was used to visualize the shape and appearance of the hPDL cells
through F-actin (an abundant component of the cell cytoskeleton)126. Figure 6 demonstrates
that the hPDL in the experimental condition (Figure 6a, 10% cyclical tension force
application) are more aligned in the direction of force application when compared to the
control condition (Figure 6b, 0% tension force application).
Figure 7 overlays both Hoechst and Rhodamine phalloidin stained images to demonstrate
that the intact nuclei are present within intact cells in both the experimental condition
(Figure 7a, 10% cyclical tension force application) and the control condition (Figure 7b,
0% tension force application). In summary, the FlexCell®FX-5000 tension system
protocol developed and described above does apply adequate force to align the cells in the
direction of force application while maintaining cell viability. Therefore, this protocol was
used for the next set of experiments described below.
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a)

b)
Figure 5: Hoechst staining of 43F (P6) hPDL cells in a 3mg/mL collagen gel after 72
hours with or without 10% cyclical tension force application.
hPDL cells were plated in a TissueTrain® in a 3mg/mL collagen gel and incubated at 37°C in a
humidified atmosphere without CO2 for 72 hours in CO2-independent media with either a 10% cyclical
tension force application (a) or a 0% tension application (b). White arrows represent direction of force
application. Cells were stained with Hoechst, visualized using the DAPI channel (405nm) at 10x
magnification. Hoechst staining of the cell nuclei/DNA demonstrates that both conditions result in
viable cells as seen by the intact nuclei. Note that this experiment was repeated in triplicate and
representative data of one set of samples is presented here. Refer to Appendix A and B for data
representative of all three sets of samples.
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a)

b)
Figure 6: Rhodamine phalloidin staining of 43F (P6) hPDL cells in a 3mg/mL collagen
gel after 72 hours with or without 10% cyclical tension force application.
hPDL cells were plated in a TissueTrain® in a 3mg/mL collagen gel and incubated at 37°C in a
humidified atmosphere without CO2 for 72 hours in CO2-independent media with either a 10% cyclical
tension force application (a) or a 0% tension force application (b). White arrows represent direction
of force application. Cells were stained with Rhodamine phalloidin, visualized using the DsRed channel
(558nm) at 10x magnification. Rhodamine phalloidin staining of f-Actin within the cell cytoskeleton
demonstrates that the hPDL cells are more aligned in the direction of force application than without
force application. Note that this experiment was repeated in triplicate and representative data of one
set of samples is presented here. Refer to Appendix A and B for data representative of all three sets of
samples.
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a)

b)
Figure 7: Overlay of Hoechst and Rhodamine phalloidin staining of 43F (P6) hPDL
cells in a 3mg/mL collagen gel after 72 hours with or without 10% cyclical tension
force application.
hPDL cells were plated in a TissueTrain® in a 3mg/mL collagen gel and incubated at 37°C in a
humidified atmosphere without CO2 for 72 hours in CO2-independent media with either a 10% cyclical
tension force application (a) or a 0% tension application (b). White arrows represent direction of force
application. Hoechst and Rhodamine phalloidin staining were visualized together to demonstrate that
viable nuclei are present within intact cells. Refer to Appendix A and B for data representative of all
three sets of samples.
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4.1.1

Troubleshooting the FlexCell®FX-5000 Tension system
protocol

While developing the FlexCell®FX-5000 Tension system protocol, it was determined that
two key elements were essential for the success of the experiment: concentration of
collagen and culture medium.
Firstly, a concentration of at least 3mg/mL collagen (Nutragen®) gel is required. Initially,
the protocol completed was using a collagen concentration of 1mg/mL which was too dilute
to even solidify in the TissueTrain®. A modification to the protocol included increasing
the collagen gel concentration to 2mg/mL and while the gels did solidify adequately in the
TissueTrain®, once 10% force application was added when in the FlexCell®FX-5000 unit,
the collage gels ripped apart. Finally, increasing the collagen concentration to 3mg/mL
allowed the gels to fully set and survive the 10% tension force application for the full 72
hours.
Secondly, the FlexCell®FX-5000 unit was connected to an incubator that did not have a
CO2 supply. In a typical hPDL cell culture using DMEM, 5% CO2 is added and acts as a
buffer allowing the culture medium to maintain a physiologic pH of approximately 7.35 to
7.45 while the cells are growing and passaged127. However, adding an external source of
CO2 to the FlexCell®FX-5000 unit was not possible with the current set up. As such, an
alternative buffer was required. Initially, DMEM plus a buffer of 25mM HEPES was used
for a set of FlexCell®FX-5000 experiments however, imaging revealed that the cells were
not viable. Hoechst staining revealed damaged nuclei as seen by their diluted, rounded
shape (Figure 8) and Rhodamine Phalloidin staining revealed atypical cell morphology
(Figure 9) in comparison to the hPDL cells shown in Figures 5 and 6. Figure 10 overlays
both Hoechst and Rhodamine phalloidin stained images.
Additionally, when the TissueTrain® culture plates were inspected visually, the culture
medium was a bright pink colour, indicating a pH that was too high and the HEPES buffer
was inadequate127. Therefore, an alternative cell culture medium/buffering system was
used. For this, CO2-independent medium (GIBCO) – a non-HEPES-containing medium
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with a proprietary buffering system – was ordered and an additional FlexCell®FX-5000
tension experiments was completed and the resulting hPDL cells were viable and intact
(Data presented in Figures 5, 6 and 7).
In summary, it is essential that a collagen gel of at least 3mg/mL Nutragel® and CO2independent medium (GIBCO) is used when completing tension experiments on hPDL
cells using the FlexCell®FX-5000 tension system and TissueTrain® culture plates.
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a)

b)
Figure 8: Hoechst staining of 43F (P5) hPDL cells in a 3mg/mL collagen gel after 72
hours with or without 10% cyclical tension force application.
hPDL cells were plated in a TissueTrain® in a 3mg/mL collagen gel and incubated at 37°C in a
humidified atmosphere without CO2 for 72 hours in DMEM+25mM HEPES with either a 10% cyclical
tension force application (a) or a 0% tension application (b) and stained with Hoechst, visualized using
the DAPI channel (405nm) at 10x magnification. White arrows represent direction of force application.
Hoechst staining demonstrates many damaged nuclei as seen by the diluted, rounded shape.
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a)

b)
Figure 9: Rhodamine phalloidin staining of 43F (P5) hPDL cells in a 3mg/mL collagen
gel after 72 hours with or without 10% cyclical tension force application.
hPDL cells were plated in a TissueTrain® in a 3mg/mL collagen gel and incubated at 37°C in a
humidified atmosphere without CO2 for 72 hours in DMEM+25mM HEPES with either a 10% cyclical
tension force application (a) or a 0% tension force application (b) and stained with Rhodamine
phalloidin, visualized using the DsRed channel (558nm) at 10x magnification. White arrows represent
direction of force application. Rhodamine phalloidin staining demonstrates hPDL cells have an
atypical morphology.
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a)

b)

Figure 10: Overlay of Hoechst and Rhodamine phalloidin staining of 43F (P5) hPDL
cells in a 3mg/mL collagen gel after 72 hours with or without 10% cyclical tension
force application.
hPDL cells were plated in a TissueTrain® in a 3mg/mL collagen gel and incubated at 37°C in a
humidified atmosphere without CO2 for 72 hours in DMEM+25mM HEPES with either a 10% cyclical
tension force application (a) or a 0% tension application (b). White arrows represent direction of force
application. The hPDL cells are not viable and are of have an atypical morphology.
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4.2 Gene expression in hPDL cells with or without cyclical
tension force application
Changes in PSTN, ALP, BSP and CEMP-1 expression was evaluated in three samples of
adult hPDL cells (28-year-old male, 28M (P5); 38-year-old female, 38F (P4); 31-year-old
male, 31M (P5)) in the presence or absence of cyclical tension force application using the
FlexCell®FX-5000 Tension system protocol describe above.
An additional force level and two additional time points were added such that gene
expression was evaluated at 0%, 10% and 20% for either 0, 24 or 72 hours. Note that the
sample size of this experiment was small and as such the results are presented with each
hPDL sample separately using descriptive observations of the data rather than a
comprehensive statistical analysis.

4.3 Expression of PSTN in hPDL cells with or without
cyclical tension force application
Figure 11 demonstrates the fold change in gene expression of PSTN in the 28M (11a), 38F
(11b) and 31M (11c) hPDL cells. Similar to the results previously published by Wilde et
al., 2003 and Rangiani et al, 2015, PSTN expression increased over time with the
application of tension force95,102. The results among the three groups were similar for all
time points at 0% force application (where minimal changes were observed in PSTN
expression) and 10% and 20% force applications (where a general trend of increased PSTN
expression over time was noted). The 28M hPDL cells had the greatest fold increase in
PSTN expression when compared to the 38F and 31M hPDL cells at both 24 and 72 hours
at 20% tension force application. Refer to Appendix C for a table presenting the numerical
data visualized on Figure 11.
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4.4 Expression of ALP in hPDL cells with or without cyclical
tension force application
Figure 12 demonstrates the fold change in gene expression of ALP in the 28M (12a), 38F
(12b) and 31M (12c) hPDL cells. Similar to the results previously published by Yamaguchi
et al., 1996, ALP expression decreased over time with the application of tension force54.
The results among the three groups were similar for all time points at 0%, 10% and 20%
with an overall trend of decreasing ALP expression over time. The 28M hPDL cells did
show an increase in ALP expression from 0 hours to 24 hours at 20% tension force
application that did decrease again by 72 hours. A similar trend was seen with the 38F
hPDL cells which showed an increase in ALP expression from 0 hours to 24 hours at 10%
tension force application that did decrease again by 72 hours. Refer to Appendix C for a
table presenting the numerical data visualized on Figure 12.

4.5 Expression of CEMP-1 in hPDL cells with or without
cyclical tension force application
Figure 13 demonstrates the fold change in gene expression of CEMP-1 in the 28M (13a),
38F (13b) and 31M (13c) hPDL cells. Overall, the general trend appears to be such that
expression of CEMP-1 decreased over time with or without the application of tension force.
The 38F hPDL cells did show a maintenance of CEMP-1 expression levels with the
application of either 10% or 20% tension force when compared to hPDL cells without the
application of tension (where CEMP-1 expression decreased). Other observations include
a slight increase in CEMP-1 expression for the 31M hPDL cells at 24 hours with 20% force
application that subsequently decreased at the 72 hour time point. Refer to Appendix C for
a table presenting the numerical data visualized on Figure 13.
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4.6 Expression of BSP in hPDL cells with or without cyclical
tension force application
There is no data to present demonstrating the fold change in gene expression of BSP in
the 28M, 38F and 31M hPDL cells. The results from the RTqPCR analysis using the BSP
probe either came up as an error or a value of zero.
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a)

b)

c)

Figure 11: Fold change in PSTN expression over time at various tensile force levels.
hPDL cells isolated from a 28-year-old male, 28M (a), a 38-year-old female, 38F (b) and a 31-year-old
male, 31M (c) were plated in triplicate in a TissueTrain® with a 3mg/mL collagen gel and incubated
at 37°C in a humidified atmosphere without CO2 for 72 hours with either a 0%, 10% or 20% cyclical
tension force application. Data was normalized to levels of 18S ribosomal RNA, relative to the value at
0 hours and presented as the mean fold change in expression of PSTN over time for each force level.
Expression of PSTN appears to increase when cyclical tension force is applied.

43

a)

b)

c)

Figure 12: Fold change in ALP expression over time at various tensile force levels.
hPDL cells isolated from a 28-year-old male, 28M (a), a 38-year-old female, 38F (b) and a 31-year-old
male, 31M (c) were plated in triplicate in a TissueTrain® with a 3mg/mL collagen gel and incubated
at 37°C in a humidified atmosphere without CO2 for 72 hours with either a 0%, 10% or 20% cyclical
tension force application. Data was normalized to levels of 18S ribosomal RNA, relative to the value at
0 hours and presented as the mean fold change in expression of ALP over time for each force level. In
general, the expression of ALP decreases over time when cyclical tension force is applied. However,
for both the 28M hPDL cells at 20% and 38F hPDL cells at 10% tension force application, the
expression of ALP does appear to increase at the 24 hour time point prior to decreasing by the 72 hour
time point.
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a)

b)

c)

Figure 13: Fold change in CEMP-1 expression over time at various tensile force
levels.
hPDL cells isolated from a 28-year-old male, 28M (a), a 38-year-old female, 38F (b) and a 31-year-old
male, 31M (c) were plated in triplicate in a TissueTrain® with a 3mg/mL collagen gel and incubated
at 37°C in a humidified atmosphere without CO2 for 72 hours with either a 0%, 10% or 20% cyclical
tension force application. Data was normalized to levels of 18S ribosomal RNA, relative to the value at
0 hours and presented as the mean fold change in expression of CEMP-1 over time for each force level.
In general, expression of CEMP-1 appears to decrease over time with or without the application of
tension force.
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Chapter 5 – Discussion
5.1 Objective 1 – To establish and validate a 3D culture
method for application of tension to human PDL cells in
a 3-Dimensional collagen gel
A protocol for applying tension to hPDL cells using the FlexCell®FX‑5000 Tension
system was developed. After some troubleshooting various different culture media and
concentrations of collagen, it was determined that a CO2-independent medium (GIBCO)
and a concentration of 3mg/mL of collagen and was necessary to maintain TissueTrain®
integrity and cell viability throughout the experiment. Fluorescent microscopy was used to
confirm that cells were still viable after 72 hours of 10% tension force application, and that
the cells appeared qualitatively more aligned in the direction of force application (as shown
in Figures 3, 4 and 5).
For this experiment, a cyclical loading protocol was used (5 second stretch followed by a
5 second relax) to replicate how a tooth might experience force during OTM. For example,
when using sliding mechanics, teeth are “walked” along the continuous arch wire in a
mesio-distal direction via a series of cyclical force applications111. Tooth movement starts
with friction alone as the crown tips after which elastic binding is added when the tooth
tips enough to bring the corners of the bracket into contact with the wire111. As root
movement catches up with the crown, elastic binding is reduced and the tooth is back to
experiencing friction alone111.
Note that it was hypothesized that the hPDL cells would appear aligned perpendicular to
the direction of force application as this was the trend seen by Oortgiesen et al., 2012. In
their experiment, mouse PDL fibroblasts were seeded in a 3-dimensional collagen gel after
which an 8% tension force load was applied122. After 24 hours of stretching, the PDL
fibroblasts were elongated and oriented perpendicular to the direction of tension force
application122. However, when evaluating the cell alignment in the hPDL cells using the
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FlexCell®FX-5000 system, the cells appeared more aligned parallel to the direction of
force application. This discrepancy could be due to various reasons.
Firstly, the cell type used by Oortgiesen et al., 2012 was rodent PDL fibroblasts while the
cells used in this experiment were derived from human PDL. Additionally, the device used
to apply the tension forces were different. Oortgiesen et al., 2012 used a moving bracket
and coverslip to apply a purely linear force. However, in this experiment, the
FlexCell®FX-5000 system applies the tension force using a vacuum that stretches the
collagen gel down and around the loading post producing equibiaxial (or circumferential)
strain. Interestingly, the alignment was more prominent in the peripheral of the gels for
both the rodent PDL fibroblasts and the hPDL cells122.

5.1.1

Limitations of the study and suggestions for future studies

The first limitation of this portion of the study is reflected by the age of the hPDL cells
used. It is known that the ability of PDL tissue to regenerate form and function declines
with age128,129. The cells used for this fluorescent microscopy experiment were from a 43year-old female. Orthodontics is more commonly performed in adolescents than adults as
seen from a survey conducted by the American Association of Orthodontics in 2010
whereby 27% of orthodontic patients were adults130. As such, whereas PDL cells from a
patient of 43-years-old might be acceptable to study periodontal disease, it is preferable
that PDL cells from a younger donor be used in the field of orthodontic research. It is
suggested that this florescent microscopy protocol be repeated on hPDL cells from a
younger donor to evaluate whether age has an effect on the PDL cell’s ability to respond
to tensile strain.
Secondly, while the hPDL cells were plated in triplicate on the TissueTrain® for each
experimental condition, this experiment was only completed with one set of hPDL cells
(43F, P6). Repeating the experiment with other hPDL cells would strengthen the findings
and perhaps pick up on some trends that are were not perceived on one set alone.

47

Finally, the fluorescent microscopy images are a 2-dimensional representation of a 3dimentional object. Sectioning the gel after fixation prior to imaging may have given a
more accurate representation of how the cells were aligned with regards to force
application.

5.2 Objective 2 – To evaluate CEMP-1 gene expression
during cyclical tensile force
The protocol outlined and discussed in Objective 1 was used to evaluate gene expression
in hPDL cells with or without the application of tension. While CEMP-1 was the original
focus of this research project, this protocol was also used to evaluate additional genes
(PSTN, ALP and BSP) with known responses to tension strain to ensure the protocol
developed was valid. Of importance, since only three different hPDL samples were used
(28M (P5), 38F (P4), 31M (P5)) results are discussed in terms of qualitative observations
rather than quantification of values and statistics.

5.2.1

Periostin expression increases with the application of tension

Periostin is highly expressed in the periodontal ligament, is required for wound healing and
remodeling and is required to maintain PDL integrity during mechanical loading101,131.
Additionally, it has been shown that periostin is upregulated in the compression zone
relative to the tension zone during orthodontic tooth movement95. In other words, periostin
was upregulated in both zones of compression and tension however it was upregulated to
a greater degree in the zone of compression relative to the zone of tension95.
As a general trend, it is shown that periostin levels increase with the application of tension.
This is in alignment with the previous research by Wilde et al., 2003. This effect was seen
most prominently in the 28M samples with an approximately 5.5-fold increase in PSTN
expression at both 24 and 72 hours with 20% tension force application. The maximum fold

48

increase in PSTN expression for the other two samples (38F and 31M) was no greater than
3-fold.
Perhaps this increased fold change in expression of PSTN in 28M hPDL cells was due to
the fact that these hPDL cells came from the youngest donor (28-year-old male). Given
that periostin is involved in maintaining PDL integrity during mechanical loading and that
the ability to regenerate the PDL decreases with age, it follows that the hPDL cells from
the youngest donor would have the highest PSTN expression128,129.

5.2.2

Alkaline phosphatase expression decreases with the
application of tension

Alkaline phosphatase is a protein enzyme involved in mineralization and calcification of
hard tissue and is a biomarker of osteoblast activity and is also known to be modulated by
orthodontic forces54. For their experiment, Yamaguchi et al., 1996 cultured human PDL
cells in a tissue culture plate with a flexible bottom and applied tension using a unit similar
to the FlexCell®FX-5000 to show that ALP expression decreased over the course of 5 days
in a magnitude-dependent manner.
As expected and similar to the findings from Yamaguchi et al., 1996, the general trend
presented in this research project shows ALP expression decreasing over time. However,
individual conditions strayed away from this trend. For example, the 28M hPDL cells
showed an increase in ALP expression from 0 hours to 24 hours at 20% tension force
application that decreased by 72 hours. A similar trend was seen with the 38F hPDL cells
which showed an increase in ALP expression from 0 hours to 24 hours at 10% tension
force application that decreased by 72 hours).
Of importance, it does appear that ALP expression was also shown to decrease over time
without any force application (0% tension force). Given that hypoxia has been shown to
decrease ALP expression, perhaps the cells in the middle of the 3-dimensional collagen
gels were not receiving adequate oxygenation, leading to the decrease in ALP
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expression132. However, if the cells in the middle of the collagen gels were experiencing
hypoxia, then this would be the case for all the gels, not just the samples without any force
application. Subsequently, determining if the decrease in ALP expression was due to
hypoxia or tension would not be possible.
An alternative explanation for the trends seen with ALP expression could be due to the fact
that only three hPDL samples were tested. It is likely that ALP expression at 0% force level
is relatively unchanged over time but too few samples were evaluated to pick up on a
specific trend or complete any statistics.

5.2.3

Expression of bone sialoprotein was not evaluated

As mentioned in the results section, there was no data to present regarding BSP expression
in either of the 28M, 38F and 31M hPDL cells under any condition. The results from the
RTqPCR analysis using the BSP probe either came up as an error or a value of zero.
Given that all the genes (PSTN, ALP, BSP, CEMP-1 and 18S) were run on the same set of
plates under the same RTqPCR experimental conditions, it can be presumed the issue was
with the probe, not the experimental technique. Perhaps the probe vial became
contaminated or exposed to too much light thus reducing its effectiveness.

5.2.4

Cementum Protein-1 expression decreases with the
application of tension

Given that CEMP-1 is expressed in the PDL cementoblastic cell layer and PDL cell
populations, has been shown to enhance cementoblast differentiation and is postulated to
have a key role in cementum repair, it was hypothesized that CEMP-1 expression would
increase with the application of tension, similar to how osteoblastic activity increases in
the zone of tension during orthodontic tooth movement113,133,134.

50

However, contrary to the hypothesis, the general trend appears to be such that expression
of CEMP-1 decreased over time with or without the application of tension force. This was
the case for both the 28M and 31M hPDL samples for most time points at all force levels.
Note that there was a relative increase in CEMP-1 expression (or perhaps more of a
maintenance of CEMP-1 levels) in the 31M hPDL cells at the 24 hour time point at 20%
tension force application that subsequently decreased by the 72 hour time point.
Interestingly, the 38F hPDL cells did appear to show a maintenance of CEMP-1 expression
levels with the application of either 10% or 20% tension force over time when compared
to no application of tension force whereby CEMP-1 expression decreased. Combining this
information with the fact that there was a relative increase (or maintenance) of CEMP-1
levels at the 24 hour time point in the 31M cells at 20% force application, perhaps there
was simply not enough samples evaluated to distinguish this specific expression trend for
CEMP-1 when under tensile force.
If the true trend is that of the one seen in the 38F hPDL cells (maintenance of CEMP-1
expression with the application of tension force) and knowing that CEMP-1 has a key role
in cementogenesis and cementum repair, then perhaps the hPDL cells only need to maintain
their CEMP-1 expression while undergoing mechanical loading (to “protect” the
cementum). Whereas if there is no mechanical loading, the cells do not need to maintain
their CEMP-1 expression. Understanding that this is pure conjecture without any scientific
basis, the inconsistent data with regards to CEMP-1 expression is more realistically due to
small sample size.

5.2.4
5.2.4.1

Limitations of study and suggestions for future studies
Small and limited sample size

As already mentioned, the most significant flaw with the data presented in this study is the
small samples sizes for both the fluorescent microscopy and gene expression assays. In
particular, a sample size of three was not adequate to elucidate specific trends seen in the
differential gene expression with or without tension force application. There was simply
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not enough data to complete a statistical analysis and as such, evaluation of the data was
purely qualitative. However, this does not mean that the data presented is of no value.
Now that a protocol to apply tension to hPDL cells has been developed (Objective 1), more
hPDL samples can be easily evaluated and added to the data presented, eventually
acquiring enough data for a statistical analysis. Furthermore, once more hPDL samples are
added, other factors such as effect of age or gender on expression of PSTN, ALP, CEMP1 (and BSP) can be evaluated.
For example, this study used hPDL cells from relatively older donors (no younger than 28
years) whereas 73% of orthodontic patients are adolescents135. Therefore, the data
presented in this study might not be as relevant to younger patients undergoing orthodontic
treatment. Additionally, since the protocol involves isolating total mRNA, it would be
relatively simple to evaluate other genes of interest using RTqPCR as it would entail simply
purchasing different probes of interest.

5.2.4.2

Comparison of gene expression during tension and
compression

Once the gene expression profiles of hPDL cells under tension using the protocol described
in this study has been more thoroughly investigated, it would be interesting to see how
gene expression changes when the cells are under compression.
For example, it is known that PSTN expression increases in both the tension and
compression zones. However, expression does increase more in the zone of compression
relative to the zone of tension so perhaps other genes are similarly regulated95. FlexCell®
International Corporation does offer another unit (FlexCell®FX-5000C) with BioPress™
culture plates which applies positive air pressure to compress cells and can be programmed
to mimic in vivo conditions.
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5.2.4.3

Force levels of the FlexCell®X-5000 Tension system

Another limitation to this study is that the amount of tension applied to the hPDL cell
samples with the FlexCell®FX-5000 Tension system is gauged in terms of percent force.
For example, the condition used in this experiment include 0%, 10% and 20% force. This
amount of force is related to the proposed percent increase in length of cells in an
equibiaxial direction during strain rather than an actual amount calculated in Newtons (N)
or gram-force (gm). For example, tipping of a tooth requires 35-60gm whereas only 1020gm is required to intrude a tooth1.
Given that a force gauge is not a component of the FlexCell®FX-500 Tension system unit,
it is not known how much force was applied and whether the amount of force applied
during these experiments is clinically relevant. Perhaps a device could be fabricated to
determine the precise amount of force generated by the FlexCell®FX-5000 Tension system
so that a clinically relevant tension amount of force can be used.

5.2.4.4

Confirmation that gene expression activity relates to protein
activity

By using RTqPCR to evaluate expression of PSTN, ALP and CEMP-1, this only provides
information with regards to the amount of that specific mRNA present in the cells but does
not provide any information with regards to whether or not the mRNA becomes a fully
formed and functional product.
As such, once the gene expression profiles have been more conclusively elucidated by
adding more hPDL samples, it is recommended that a Western Blot analysis be performed
on the hPDL cell samples with or without application of tension to correlate the amount of
mRNA expression with amount of resulting protein.
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5.2.4.5

Power failure during mRNA isolation

As mentioned previously, there was a building-wide power failure during the mRNA
isolation of samples from the 31M hPDL cells. As such, the majority of 31M hPDL samples
were on the RNeasy Mini Kit (QIAGEN) column for over one hour rather than the
recommended 2 minutes. This affected the overall yield of the mRNA for those samples
and perhaps may have skewed the data if mRNA corresponding to PSTN, ALP and CEMP1 was destroyed.

5.2.4.6

CEMP-1 is only found in humans

CEMP-1 is a cementum molecule that is only found in humans meaning that there is no
animal model113,134. This means that in order to study this novel protein, PDL cells must be
extracted from human donor samples which increases the complexity of ethics approval
and decreases the number of samples available to study.
Contrarily, Periostin is found in mice and its role in wound healing can be evaluated in
depth by taking advantage of the murine model. For example, mice were engineered to lack
the periostin gene (Postn-/-) and were shown to have a significantly reduced percent of
wound closure when compared to mice that had the periostin gene (Postn+/+)136. This
provides extremely strong evidence for the importance of Periostin during wound healing.
Such a study is not possible with CEMP-1.

5.3 Clinical relevance
While the research presented in this study does not have a direct clinical relevance, it has
opened doors for future research that might eventually help guide how orthodontic
treatment is completed. For example, once the gene expression profile of CEMP-1 has been
elucidated and its protein function more thoroughly evaluated, perhaps genetic testing
might help determine whether or not a patient will be more susceptible to external root
resorption during orthodontic treatment.
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If it is determined that CEMP-1 does have a cementum-protective effect as proposed and
discussed in this study, then perhaps individuals with a reduced level of CEMP-1
expression be identified and their orthodontic treatment modified with slower tooth
movement and using less force to decrease the likelihood of root resorption. However, as
with most studies, many additional studies are required to clarify these recommendations.
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Chapter 6 – Conclusions
Objective 1 – To establish and validate a 3D culture method for application of tension to
human PDL cells in a 3-Dimensional collagen gel
•

The FlexCell®FX-5000 Tension system protocol developed using CO2independent medium (GIBCO) and 3mg/mL collagen is a valid method to evaluate
gene expression in human PDL ligament cells.

Objective 2 – To evaluate CEMP-1 gene expression during cyclical tensile force
•

The control genes performed as expected. Periostin expression increased with the
application of tension and alkaline phosphatase expression decreased with the
application of tension.

•

In certain samples, CEMP-1 expression appeared to decrease over time regardless
of amount of force application and was not dependent on time; however, in other
samples, CEMP-1 expression also appeared to be maintained with the application
of tension force.

•

Given the small sample size, statistical analysis was not performed and as such only
qualitative observations were made. Repeating the experiment with more sets of
human PDL cells (preferably from younger donors) is required to make quantitative
observations of any statistically significant trends.
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Appendices
Appendix A: Representative images of triplicate hPDL cell samples isolated from a
43-year-old female without application of cyclical tension force incubated at 37°C in
a humidified atmosphere without CO2 for 72 hours.
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Appendix B: Representative images of triplicate hPDL cell samples isolated from a
43-year-old female with the application of 10% cyclical tensile force incubated at
37°C in a humidified atmosphere without CO2 for 72 hours.
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Appendix C: Numerical data represented by graphs in Figures 4, 5 and 6
Data presented was normalized to levels of 18S ribosomal RNA, relative to the value at 0
hours and presented as the mean fold change in expression of either PSTN, ALP and
CEMP-1 over time for each force level.
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